Michael LaBarre
Chief Tech/Sci/R&D Officer presso HALOZYME THERAPEUTICS, INC.
Patrimonio netto: 7 M $ in data 31/03/2024
Profilo
Michael J. LaBarre è direttore tecnico e vicepresidente senior della Halozyme Therapeutics, Inc. Nella sua carriera passata il Dr. LaBarre ha ricoperto la posizione di Direttore-Analytical & Protein Biochemistry presso Biogen, Inc. e Direttore-Analytical & Formulation Sciences presso IDEC Pharmaceuticals Corp. (una sussidiaria di Biogen, Inc.) e vicepresidente dello sviluppo dei prodotti presso la Paramount BioSciences LLC. Il dottor LaBarre ha conseguito un dottorato presso l'Università dell'Arizona e una laurea presso la Stony Brook University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 17/04/2024 | 168 176 ( 0.13% ) | 7 M $ | 31/03/2024 |
Posizioni attive di Michael LaBarre
| Società | Posizione | Inizio |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Precedenti posizioni note di Michael LaBarre
| Società | Posizione | Fine |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/04/2006 |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | 01/12/2003 |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Corporate Officer/Principal | - |
Formazione di Michael LaBarre
| Stony Brook University | Undergraduate Degree |
| University of Arizona | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
- Borsa valori
- Insiders
- Michael LaBarre
